canakinumab
Ligand Summary
a human anti-interleukin-1beta monoclonal antibody for treatment of cryopyrin-associated periodic syndrome
ChEMBL: CHEMBL1201834
DrugCentral: 4952
LyCHI: canakinumab
Target Activities
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
ANTIBODY BINDING | ||||||